CHEST 2019
Home Oxygen Use Associated With Worsened Physical Function in COPD and IPF
Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.
Your search for supplemental oxygen returned 28 results
ESC 2017
Does Oxygen Therapy Reduce Mortality in Suspected Acute MI?
Routine use of supplemental oxygen does not reduce one-year all-cause mortality versus ambient air
News
Oxygen Therapy for Mild COPD: Is It Beneficial?
Researchers find oxygen therapy does not improve quality of life, forestall hospitalization, lengthen lives
ID Week 2022
High-Dose Dexamethasone May Be Harmful for Patients With COVID-19
Current evidence indicates that a 6mg dose of dexamethasone daily is effective for improving COVID-19 outcomes among patients receiving supplemental oxygen.
News
Convalescent Plasma Not Efficacious in Hospitalized COVID-19 Patients
No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen
CHEST 2022
New Machine Learning Tool to Predict Pneumonia Progression Outperforms PSI
Investigators developed and validated a machine learning tool providing an early indication of disease progression in community-acquired pneumonia.
News
Asian, Black, Hispanic Patients Have Higher Pulse Oximetry Readings
Lower average oxygen delivery rates seen in association with Asian, Black, Hispanic versus White race, ethnicity
News
Dapagliflozin Does Not Improve Kidney Outcomes in Hospitalized COVID-19 Cases
Investigators report findings from a secondary analysis of the DARE-19 trial, which compared dapagliflozin with placebo in patients hospitalized with COVID-19.
News
Tocilizumab Shortage Prompts Temporary REMS Change for CAR T-Cell Therapy
Shortly after an EUA was issued, Genentech announced that tocilizumab (marketed under the brand name Actemra) was in shortage.
News
FDA Authorizes Emergency Use of Actemra for COVID-19
The EUA was issued based on 4 randomized controlled clinical trials that evaluated the efficacy and safety of Actemra in more than 5500 hospitalized patients with COVID-19.
